Molecular and cellular basis for anti-amyloid therapy in Alzheimer disease

被引：31

作者：

Gandy, S

Martins, RN

Buxbaum, J

机构：

[1] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA

[2] Edith Cowan Univ, Perth, WA, Australia

[3] Mt Sinai Sch Med, Lab Mol Neuropsychiat, Dept Neurobiol, New York, NY USA

[4] Mt Sinai Sch Med, Lab Mol Neuropsychiat, Dept Psychiat, New York, NY USA

来源：

ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 2003年 / 17卷 / 04期

关键词：

D O I：

10.1097/00002093-200310000-00011

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：259 / 266

页数：8

共 72 条

[51] APOLIPOPROTEIN-E, DEMENTIA, AND CORTICAL DEPOSITION OF BETA-AMYLOID PROTEIN [J].

POLVIKOSKI, T ;

SULKAVA, R ;

HALTIA, M ;

KAINULAINEN, K ;

VUORIO, A ;

VERKKONIEMI, A ;

NIINISTO, L ;

HALONEN, P ;

KONTULA, K .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (19) :1242-1247

[52] Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation [J].

Qiu, WQ ;

Walsh, DM ;

Ye, Z ;

Vekrellis, K ;

Zhang, JM ;

Podlisny, MB ;

Rosner, MR ;

Safavi, A ;

Hersh, LB ;

Selkoe, DJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32730-32738

[53] Effect of estrogen plus progestin on global cognitive function in postmenopausal women - The Women's Health Initiative Memory Study: A randomized controlled trial [J].

Rapp, SR ;

Espeland, MA ;

Shumaker, SA ;

Henderson, VW ;

Brunner, RL ;

Manson, JE ;

Gass, MLS ;

Stefanick, ML ;

Lane, DS ;

Hays, J ;

Johnson, KC ;

Coker, LH ;

Dailey, M ;

Bowen, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (20) :2663-2672

[54]

REBECK GW, 1993, NEURON, V11, P575

[55] A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease [J].

Refolo, LM ;

Pappolla, MA ;

LaFrancois, J ;

Malester, B ;

Schmidt, SD ;

Thomas-Bryant, T ;

Tint, GS ;

Wang, R ;

Mercken, M ;

Petanceska, SS ;

Duff, KE .

NEUROBIOLOGY OF DISEASE, 2001, 8 (05) :890-899

[56] Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model [J].

Refolo, LM ;

Pappolla, MA ;

Malester, B ;

LaFrancois, J ;

Bryant-Thomas, T ;

Wang, R ;

Tint, GS ;

Sambamurti, K ;

Duff, K .

NEUROBIOLOGY OF DISEASE, 2000, 7 (04) :321-331

[57]

SAHASRABUDHE SR, 1992, J BIOL CHEM, V267, P25602

[58] ASSOCIATION OF APOLIPOPROTEIN-E ALLELE EPSILON-4 WITH LATE-ONSET FAMILIAL AND SPORADIC ALZHEIMERS-DISEASE [J].

SAUNDERS, AM ;

STRITTMATTER, WJ ;

SCHMECHEL, D ;

GEORGEHYSLOP, PHS ;

PERICAKVANCE, MA ;

JOO, SH ;

ROSI, BL ;

GUSELLA, JF ;

CRAPPERMACLACHLAN, DR ;

ALBERTS, MJ ;

HULETTE, C ;

CRAIN, B ;

GOLDGABER, D ;

ROSES, AD .

NEUROLOGY, 1993, 43 (08) :1467-1472

[59]

Savage MJ, 1998, J NEUROSCI, V18, P1743

[60] Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease [J].

Scheuner, D ;

Eckman, C ;

Jensen, M ;

Song, X ;

Citron, M ;

Suzuki, N ;

Bird, TD ;

Hardy, J ;

Hutton, M ;

Kukull, W ;

Larson, E ;

LevyLahad, E ;

Viitanen, M ;

Peskind, E ;

Poorkaj, P ;

Schellenberg, G ;

Tanzi, R ;

Wasco, W ;

Lannfelt, L ;

Selkoe, D ;

Younkin, S .

NATURE MEDICINE, 1996, 2 (08) :864-870

← 1 2 3 4 5 6 7 8 →